Diffuse pediatric-type high grade glioma, RTK1 subtype, subclass C with SYN2 :: PPARG fusion in an older adult.

CNS OncolMar 25, 2026 (epub)
Case ReportOncology (Medical)NeurologyOpen access

Mikaela N Brentlinger, Jemini Patel, Ahmed Khan et al.

✦ AI-curated · Sources linked

Case in brief

A 66-year-old woman presented with a left frontal lobe mass and underwent surgical resection. Histology showed a high-grade glioma with pleomorphism, brisk mitotic activity, vascular proliferation and necrosis, alongside oligodendroglial-like features, nuclear clusters and small rosette-like structures. Molecular testing identified several genomic alterations, including a SYN2::PPARG fusion; DNA methylation profiling classified the tumor as diffuse pediatric-type high-grade glioma, RTK1 subtype, subclass C. After surgery, she developed herpes simplex virus 2 meningoencephalitis and died.

What made this case unusual

The tumor was classified as a pediatric-type high-grade glioma in a 66-year-old adult, and testing identified a SYN2::PPARG fusion not previously reported in glioma.

Diagnostic / clinical pearl

In an older adult with an atypical high-grade glioma, integrating histology with molecular testing and DNA methylation profiling can clarify tumor classification.

Source

Published in CNS Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.